James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,332 shares at $21.79 ($29K) on 2026-05-04, disclosed to the SEC on 2026-05-05.
Scheduled sale ($29k) by PRINCIPAL ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $193K | — | Filing → |